We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




CSF Cytokine Characteristics Defined from Children with Meningitis

By LabMedica International staff writers
Posted on 21 Jan 2020
Enteroviral meningitis (EVM) are the most common etiological agent for viral encephalitis, and are predominantly reported among children and always present as a milder clinical illness than other infectious causes which only need supportive therapy.

However, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate. More...
Appropriate antibiotics treatment is essential to optimize outcomes. Cytokines are regarded as having important roles in meningeal inflammation in patients with central nervous system (CNS) infection.

Clinical scientists at the Zhejiang University School of Medicine (Hangzhou, China) carried a retrospective study and collected cerebrospinal fluid CSF and/or blood specimens for microbiological culture, viruses, and cytokine detection. Patients were categorized into three groups: EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR); BM group: Patients with bacterial meningitis who were diagnosed as having significant CSF white blood cell counts; Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.

CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for enrichment culture. MALDI‐TOF (BRUKER, Billerica, MA, USA) was used for bacterial identification and VITEK 2 compact (bioMérieux, Marcy-l'Étoile, France) for bacterial drug sensitivity. Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BD CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences, San Jose, CA, USA). The detection of EVs was performed by using commercial one‐step real‐time RT‐PCR assay kit.

The scientists reported that 43 patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and control group. Serum IL‐6 and serum IL‐10 were lower in EVM group than BM and control group. IL‐6, IL‐10, and IFN‐γ levels showed obviously increase in CSF in EVM group, while only IL‐6 increased in CSF in BM group. CSF concentrations of cytokines IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM and BM were both higher than control group, but compared EVM group to BM group, CSF IL‐2, TNF, and IFN‐γ showed no difference between two groups.

The authors concluded that CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. However, they could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. The study was published on January 8, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Zhejiang University School of Medicine
Becton, Dickinson and Company
BRUKER
bioMérieux
BD Biosciences



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.